Advanced bioconjugation strategies: New webinar tackles complex chemistry for targeted therapeutics
Examining the critical role of PEGylation and glycosylation as bioconjugation tools for drug development.
Biosynth
Advancing diagnostics reagent development for emerging and rare diseases
Green chemistry: Navigating growing ESG challenges in pharma manufacturing
How bioconjugation is unlocking the next generation of drug development
Lilly and insitro team up to develop AI-powered siRNA metabolic drugs
Suven Pharmaceuticals to gain controlling stake in Sapala Organics
